The Secondaries WeekIbex's $87 million Israel-focused fund was the week's only secondaries close with a disclosed figure; Sun Capital and Center Rock were among three continuation vehicles reported without prices.

October 2

The Secondary OpenAres set a $1 billion target for the vehicle, which finances private-equity managers; separately, three continuation vehicles closed without reported prices.
Oct 2

The Secondary OpenForvis Mazars and PitchBook put the median at 11.7x, down from 20.4x across 702 sponsor deals worth $58.8 billion.
Oct 1

The Secondary OpenAmong the week's secondaries closes, only Ibex's carried a disclosed dollar figure; Sun Capital's Anderson Global closed with no price, size or named lead buyer.
Sep 30
The Anderson Global vehicle gives Fund VIII LPs a liquidity option or a roll, but no price, size, or lead buyer was disclosed.
September 29
AltAssets reported the close on 28 September, the week's only clean fundraising figure as larger secondaries deals printed without asset marks.
September 28
A $101 million bank sale and three GP-led continuation vehicles closed without asset-level prices, leaving the week's secondaries tape anchored to a management company's fee stream.
September 28
Three GP-led continuation vehicles closed without a mark, and the absence is the mechanism: buyers are underwriting the sponsor's valuation rather than the company underneath.
September 25
A $101 million bank balance-sheet sale and a $4.7 billion Orix–Anchorage GP stake printed; three continuation vehicles closed without an asset-level mark.
September 25
A bank's balance-sheet sale is not an asset mark, and the week's three unpriced continuation vehicles show the GP-led market still has no external anchor.
September 24
A $4.7 billion Orix–Anchorage Capital closing shows capital moving through manager economics while LP-led trades stay stalled.
September 24
BDO's research pairs a longer tail of funds past five years with sponsor expectations of higher prices, leaving voluntary LP sellers unwilling to trade below marks.
September 23
Priced LP-led trades give buyers a benchmark to use against Amulet's unpriced US Fertility continuation vehicle.
September 21
A $101 million bank position and a Dutch pension fund set one reference for the week's LP-led supply; Amulet's US Fertility continuation vehicle closes with no published price, leaving buyers to run two underwriting models.
September 21
A $101 million bank position and a BlackRock agreement with a Dutch pension fund are the week's real supply story, and sellers like these price off the balance sheet rather than the asset.
September 18
Built to hand LPs an exit, the continuation vehicle has become a front door for small LPs — and their OCIO may be standing in it first.
September 18
A benchmark-free fertility continuation vehicle shows the GP-led market now prices services assets off the sponsor's mark rather than the tape.
September 17
Single-asset continuation vehicles for a fitness-equipment maker and a shipping franchise are clearing while the mega LP portfolios wait.
September 17
A $1 billion pre-hire commitment and an allocator's launch show capital now follows people.
September 16
Hong Kong panelists expect Indian secondaries exits to precede fundraises, and a negative buyout benchmark gives buyers the cover to price continuation vehicles below sponsor marks.
September 14
Indian sponsors are expected to run secondaries exits ahead of fundraises, putting the GP-led desk in the position of underwriting sponsor marks against a buyout benchmark that has just turned negative.
September 14
Venture buyers get the discount, the GP-led side gets the sponsor's number, and HarbourVest's negative quarter draws the line.
September 11
Pantheon's €1.2bn credit CV has no public benchmark; Kelso's $510m MEP CV is ordinary. Each prices on terms, not marks.
September 11
Credit's arrival in the GP-led market moves the pricing question off published comps and onto covenants, rollover terms and one lead buyer's underwriting.
September 10
The sticker price says little; the rollover, fees, and covenants will decide whether this middle-market exit works.
September 10
An 11x Saviynt rollover now has to answer to a public benchmark.
September 8
Carrick's 11x Saviynt rollover is the test of who still challenges a sponsor's mark in a GP-led market losing its independent buyers.
September 7
Carrick's 11x Saviynt rollover now has to answer to a benchmark showing buyout returns lost value.
September 7
Carrick's $255 million reinvestment is the test of whether software marks survive contact with a negative buyout quarter.
September 7
The buyout firm's new flagship, almost four times its 2019 fund, puts a sponsor's own marks at the center of continuation-vehicle pricing.
September 3
Record capital is chasing structured liquidity while the specialists that once set prices get absorbed or pivot.
September 2
The deal folds a 36-year-old secondaries specialist into EQT just as the market's hardest job moves from sourcing to pricing.
September 1
PWD's deal log shows zero classic LP-interest sales, leaving every secondaries transaction priced off the manager's own books.
August 28
This week's secondaries deals all move one way: toward liquidity on the manager's terms, priced off the manager's books.
August 27
The proposed stamp-duty legislation closes the offshore execution route and forces buyers to re-underwrite UK-linked LP stakes.
August 25
Proposed legislation removes the stamp-duty grey area that made secondaries bids harder to price.
August 25
Exponent's €1.4bn rollover of H&MV and a new Emerging-Promethean fund show GP-led structures now set the direction of the secondaries market.
August 21
The next wave of sponsor demand is flowing into loans and minority stakes rather than discounted fund purchases.
August 21
Sponsors are selling minority stakes and raising hybrid capital to get cash back to LPs — the latest workaround in a secondaries boom.
August 21
Structured debt gives a Temasek-backed manager an exit from the exit, leaving discounted bids behind.
August 20